Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
PatSnap Eureka Desktop
NEWAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisOpen Platform
NEWProfessional Services
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report How conformal cooling channel designs in injection mold tooling reduce warpage in complex polymer parts — engineering principles, thermal management, and IP landscape.
Article | Report Petosemtamab (MCLA-158) targets EGFR and LGR5 in HNSCC. Explore the Merus bispecific pipeline, Phase III design, and competitive landscape in head and neck cancer.
Article | Report How do engineers choose between ultrasonic and electromagnetic flow meters? Explore the key selection criteria, accuracy trade-offs, and application guidance.
Article | Report Gilead's lenacapavir twice-yearly injection redefines HIV PrEP. Explore PURPOSE trial results, patent landscape, and the long-acting prevention competitive landscape.
Article | Report Moderna's mRNA-1647 CMV vaccine encodes six mRNAs targeting gB and the pentameric complex. Explore the antigen design, IP landscape, and CMVictory Phase III trial context.
Article | Report How AI is reshaping simulation engineers' roles in automotive crash safety workflows — surrogate modeling, automated FEA, and IP strategy guidance.
Article | Report Comparing Pfizer Abrysvo and GSK Arexvy RSV vaccine long-term efficacy data in adults 60+: real-world outcomes, durability, and patent intelligence.
Article | Report How engineers design redundant braking architectures in autonomous vehicles to meet ISO 26262 ASIL-D requirements — key strategies, standards, and IP landscape.
Article | Report How sacituzumab govitecan and next-gen TROP2 ADCs are reshaping endometrial and urothelial cancer treatment — and what resistance mechanisms mean for the pipeline.
Article | Report How federated learning enables AI model training across distributed manufacturing sites without sharing raw data — architecture, privacy, and industrial deployment.
Article | Report Ifinatamab deruxtecan's DeLLphi-304 Phase III trial is redefining first-line small cell lung cancer treatment. Explore the science, patent landscape, and clinical implications.
Article | Report No verified patent or literature data was found for deterministic latency in industrial Ethernet for real-time robot control. Learn what this means for your research.
Article | Report Ulotaront, ralmitaront, and the TAAR1 agonist pipeline are reshaping schizophrenia and depression drug discovery. See the competitive landscape.
Article | Report Explore the key technical tradeoffs between hydrogen combustion and fuel cell powertrains for aviation — efficiency, weight, emissions, and integration challenges.
Article | Report Roche's trontinemab uses a transferrin receptor brain-shuttle to deliver amyloid-beta antibody at higher brain concentrations with a differentiated ARIA profile. Full Phase II analysis.